IGRO - ETF AI Analysis

Top Page

iShares International Dividend Growth ETF (IGRO)

Rating:62Neutral

Price Target:―

IGRO’s rating suggests it is a solid but not top-tier international dividend growth ETF, supported by strong core holdings like Novartis, Nestlé, and Roche, which bring robust profitability, cash flow, and generally positive momentum and earnings sentiment. Banks such as Royal Bank of Canada, Toronto Dominion, and Mitsubishi UFJ also add stability and reasonable valuations, though issues like high leverage, cash flow volatility, and occasional overbought or valuation concerns, along with risks such as high debt at Iberdrola, slightly weigh on the fund. The main risk factor is its concentration in a few large financial and healthcare names, where leverage, valuation, or overbought conditions could lead to short-term corrections.

Positive Factors

Strong Recent Performance

The ETF has delivered solid gains so far this year and in recent months, showing positive momentum for investors.

Global Diversification

Holdings spread across many countries, including Japan, the U.S., Europe, and other regions, help reduce the impact of problems in any single market.

Low Expense Ratio

The fund’s relatively low annual fee means more of the ETF’s returns stay in investors’ pockets over time.

Negative Factors

Heavy Financial Sector Exposure

A large portion of the portfolio is in financial companies, which can make the fund more sensitive to interest rate and banking sector risks.

Mixed Performance Among Top Holdings

While several major positions have shown strong or steady gains, a few key holdings have been weak recently, which can drag on overall returns.

Concentration in Developed Markets

Most of the ETF’s assets are in developed countries, limiting potential benefits from faster-growing emerging markets.

IGRO vs. SPDR S&P 500 ETF (SPY)

AUM1.26B

RegionGlobal Ex-U.S.

Expense Ratio0.15%

Beta0.54

IssueriShares

Inception DateMay 17, 2016

Dividend Yield2.72%

Asset ClassEquity

Index TrackedMorningstar Global ex-US Dividend Growth

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume67,119

30 Day Avg. Volume41,490

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

102.11

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering470

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

IGRO Summary

IGRO is the iShares International Dividend Growth ETF, which follows the Morningstar Global ex-US Dividend Growth index. It invests in companies outside the United States that have a history of steadily increasing their dividend payments. The fund holds well-known names like Nestlé, Novartis, Toyota, and Royal Bank of Canada, spread across many countries and sectors. Someone might invest in IGRO to diversify beyond the U.S. and seek a mix of income and long-term growth from stable global companies. A key risk is that international stocks can go up and down with global markets and currency changes.

How much will it cost me?The iShares International Dividend Growth ETF (IGRO) has an expense ratio of 0.15%, which means you’ll pay $1.50 per year for every $1,000 invested. This is lower than average for ETFs because it is passively managed, tracking an index of international dividend growth companies.

What would affect this ETF?The iShares International Dividend Growth ETF (IGRO) could benefit from global economic recovery and increased demand for dividend-paying stocks, especially in sectors like financials, healthcare, and utilities, which make up a significant portion of its holdings. However, potential risks include currency fluctuations, geopolitical tensions, and slower economic growth in international markets, which could negatively impact the performance of its top holdings and overall portfolio. Changes in interest rates or regulatory policies in key regions could also influence the ETF's future returns.

IGRO Top 10 Holdings

IGRO leans heavily on global financials and healthcare, with Canadian banks and Swiss drugmakers steering the ship. Toronto-Dominion and Mitsubishi UFJ have been rising this year, giving the fund a solid tailwind, while Royal Bank of Canada adds steady strength. On the healthcare side, Novartis and Roche are quietly boosting returns, even as Sanofi has been lagging and losing steam. Consumer staples like Nestlé and British American Tobacco are more mixed, keeping overall gains in check. With holdings spread across Canada, Europe, and Japan, IGRO offers broad non-U.S. exposure without leaning on any single country.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
BATS	British American Tobacco	3.11%	$39.31M	£89.97B	7.70%	71 Outperform
NESN	Nestlé SA	2.94%	$37.21M	CHF198.50B	0.76%	71 Outperform
NOVN	Novartis AG	2.91%	$36.78M	CHF219.30B	22.56%	80 Outperform
RHHVF	Roche Holding AG	2.90%	$36.69M	$346.33B	37.61%	73 Outperform
RY	Royal Bank Of Canada	2.82%	$35.68M	$279.35B	36.74%	75 Outperform
TD	Toronto Dominion Bank	2.27%	$28.65M	$203.40B	49.87%	74 Outperform
SAN	Sanofi	2.23%	$28.24M	€86.11B	-11.48%	75 Outperform
IBE	Iberdrola	2.19%	$27.65M	€134.07B	27.16%	67 Neutral
	―	2.15%	$27.21M	―	―	―
8306	Mitsubishi UFJ Financial Group	2.14%	$27.08M	¥41.53T	40.32%	76 Outperform

IGRO Technical Analysis

Technical Analysis Sentiment

Negative

Last Price―

Price Trends

50DMA

91.28

Negative

100DMA

89.28

Negative

200DMA

86.57

Positive

Market Momentum

MACD

-0.49

Positive

RSI

39.02

Neutral

STOCH

32.70

Neutral

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For IGRO, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 90.95, equal to the 50-day MA of 91.28, and equal to the 200-day MA of 86.57, indicating a neutral trend. The MACD of -0.49 indicates Positive momentum. The RSI at 39.02 is Neutral, neither overbought nor oversold. The STOCH value of 32.70 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IGRO.

IGRO Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
IGRO	―	―	$1.26B	0.15%	62 Neutral
VIGI	―	―	$8.93B	0.07%	66 Neutral
CGIC	―	―	$2.58B	0.54%	59 Neutral
WCMI	―	―	$2.09B	0.85%	59 Neutral
ILOW	―	―	$1.83B	0.50%	61 Neutral
IDVO	―	―	$1.46B	0.65%	66 Neutral

Performance Comparison

IGRO

iShares International Dividend Growth ETF

88.76

10.76

13.79%

VIGI

Vanguard International Dividend Appreciation ETF

―

CGIC

Capital Group International Core Equity ETF

―

WCMI

First Trust WCM International Equity ETF

―

ILOW

AB International Low Volatility Equity ETF

―

IDVO

Amplify International Enhanced Dividend Income ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents